Aull & Monroe Investment Management Corp Bristol Myers Squibb CO Transaction History

Aull & Monroe Investment Management Corp

$217 Million
Q1 2024

A detailed history of Aull & Monroe Investment Management Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Aull & Monroe Investment Management Corp holds 15,621 shares of BMY stock, worth $619,528. This represents 0.39% of its overall portfolio holdings.

Number of Shares

15,621

Previous 17,921 12.83%

Holding current value

$619,528

Previous $919,000 7.83%

% of portfolio

0.39%

Previous 0.46%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$47.98 - $54.4 $110,354 - $125,120	-2,300 Reduced 12.83%	15,621 $847,000
Q4 2023 Jan 25, 2024	SELL	$48.48 - $57.85 $38,784 - $46,280	-800 Reduced 4.27%	17,921 $919,000
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $26,166 - $29,257	-452 Reduced 2.36%	18,721 $1.09 Million
Q2 2023 Jul 24, 2023	SELL	$63.71 - $70.74 $3,185 - $3,536	-50 Reduced 0.26%	19,173 $1.23 Million
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $8,739 - $9,912	-133 Reduced 0.69%	19,223 $1.33 Million

Q4 2022 Feb 07, 2023	SELL	$68.48 - $81.09 $45,950 - $54,411	-671 Reduced 3.35%	19,356 $1.39 Million
Q1 2022 May 02, 2022	BUY	$61.48 - $73.72 $67,628 - $81,092	1,100 Added 5.81%	20,027 $1.46 Million
Q2 2021 Jul 28, 2021	BUY	$61.91 - $67.42 $20,430 - $22,248	330 Added 1.77%	18,927 $1.27 Million
Q1 2021 Apr 19, 2021	BUY	$59.34 - $66.74 $282,577 - $317,815	4,762 Added 34.42%	18,597 $1.17 Million
Q4 2020 Feb 02, 2021	SELL	$57.74 - $65.43 $35,625 - $40,370	-617 Reduced 4.27%	13,835 $858,000
Q2 2020 Jul 28, 2020	SELL	$54.82 - $64.09 $32,946 - $38,518	-601 Reduced 3.99%	14,452 $850,000
Q4 2019 Feb 04, 2020	BUY	$49.21 - $64.19 $21,455 - $27,986	436 Added 2.98%	15,053 $967,000
Q3 2019 Oct 30, 2019	SELL	$42.77 - $50.71 $89,817 - $106,491	-2,100 Reduced 12.56%	14,617 $741,000
Q2 2019 Jul 29, 2019	SELL	$44.62 - $49.34 $30,341 - $33,551	-680 Reduced 3.91%	16,717 $758,000
Q1 2019 Apr 18, 2019	SELL	$45.12 - $53.8 $4,512 - $5,380	-100 Reduced 0.57%	17,397 $830,000
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $111,075 - $144,037	-2,278 Reduced 11.52%	17,497 $910,000
Q3 2018 Oct 31, 2018	SELL	$55.19 - $62.25 $16,557 - $18,675	-300 Reduced 1.49%	19,775 $1.23 Million
Q2 2018 Jul 24, 2018	SELL	$50.53 - $62.98 $10,106 - $12,596	-200 Reduced 0.99%	20,075 $1.11 Million
Q1 2018 May 10, 2018	BUY	$59.92 - $68.98 $5,992 - $6,898	100 Added 0.5%	20,275 $1.28 Million
Q4 2017 Jan 29, 2018	SELL	$59.94 - $65.35 $11,988 - $13,069	-200 Reduced 0.98%	20,175 $1.24 Million
Q3 2017 Oct 26, 2017	SELL	$55.23 - $63.74 $16,569 - $19,122	-300 Reduced 1.45%	20,375 $1.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	20,675	20,675 $1.15 Million

Others Institutions Holding BMY

# of Institutions

2,553

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $84.3B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aull & Monroe Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Aull & Monroe Investment Management Corp with notifications on news.

Account

Aull & Monroe Investment Management Corp Bristol Myers Squibb CO Transaction History